d-(RYTVELA)
Product Specifications
UNSPSC Description
d-(RYTVELA) is a specific inhibitor of human thymocyte proliferation with an IC50 of 1 nM. d-(RYTVELA) inhibits IL-1–induced signaling pathways[1].
Target Antigen
Interleukin Related
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/d-rytvela.html
Solubility
10 mM in DMSO
Smiles
OC(C=C1)=CC=C1C[C@@H](NC([C@H](N)CCCNC(N)=N)=O)C(N[C@H]([C@@H](O)C)C(N[C@H](C(C)C)C(N[C@H](CCC(O)=O)C(N[C@H](CC(C)C)C(N[C@H](C)C(O)=O)=O)=O)=O)=O)=O
Molecular Weight
850.96
References & Citations
[1]Tiffany Habelrih, et al. Pharmacodynamic characterization of rytvela, a novel allosteric anti-inflammatory therapeutic, to prevent preterm birth and improve fetal and neonatal outcomes. Am J Obstet Gynecol. 2023, 228, 4.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P10353/d-RYTVELA-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P10353/
Clinical Information
No Development Reported
CAS Number
868844-53-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
